The Pediatric Infectious Disease Journal · 2018 · 17 citations · 6 references
MedicineMaternal HealthObstetricsBone MetabolismMaternal-fetal MedicineWomen's HealthAntiretroviral TherapyBone HealthBone QualityMetabolic Bone DiseasePregnancyBone Matrix Mineral ContentBone Mineral DensityBone Mineral Density DeclineDrug Effects On Bone DensityHiv Coinfection In PregnancyMaternal Bone HealthPilot Study DesignTenofovir Therapy
The effects of maternal tenofovir use on infant bone mineral content (BMC) and bone mineral density (BMD) were evaluated in a pilot study of HIV/Hepatitis B-coinfected pregnant women in China. BMD and BMC were assessed at age 6 months of life in 14 tenofovir-exposed and 13 unexposed infants. Trends toward lower BMC and BMD were observed in infants exposed to maternal tenofovir but were not statistically significant.
6
Stefano Mora, Vania Giacomet, Sara Stucchi et al. · Antiviral Therapy · 2011 · 65 citations · Full text
Denise L. Jacobson, Kunjal Patel, Paige L. Williams et al. · The Pediatric Infectious Disease Journal · 2016 · 26 citations · Full text